ExAdEx-Innov at the International Symposium by SFC 2025

ExAdEx-Innov proudly contributed to the 19th International Symposium “Cosmetic Science: Shaping the Future” organized by the Société Française de Cosmétologie (SFC) in Paris on December 2–3, 2025 Body-Site-Specific Tissue Insights Facial skin has distinct features compared to other body regions, and its layers undergo critical changes with aging and stress. These alterations contribute to cosmetic […]

Poster session at Obesity Week 2025 by Resalis Therapeutics

EXADEX-INNOV is excited to announce that Resalis Therapeutics will present preclinical translational data at Obesity Week 2025, including results obtained on our human adipose tissue models Novel Therapy: Targeting miR-22 for Energy Expenditure The poster showcases RES-010, a novel antisense oligonucleotide developed by Resalis Therapeutics to inhibit miR-22, an important post-transcriptional regulator of metabolic pathways in […]

ExAdEx-Innov at the 35th IFSCC Congress in Cannes

EXADEX-INNOV will be participating in the 35th IFSCC Congress, the world’s premier cosmetic science congress, taking place in Cannes from September 15–18, 2025   VISIT US AT BOOTH 14bis Join us at Booth 14bis to discover our latest advancements in cosmetic science. We’ll be showcasing our brand-new models, innovative research tools, and state-of-the-art 3D imaging […]

Nanofat Use in Regenerative Medicine: A Systematic Literature Review

ExAdEx-Innov contributes to Landmark Review on Nanofat in Regenerative Medicine We are delighted to announce the publication of our latest collaborative research with our partners from Center for Cardiovascular and Nutrition Research (C2VN) in Marseille, France: « Nanofat Use in Regenerative Medicine: A Systematic Literature Review and Consensus Recommendations from Expert Opinions, » now featured in Facial […]

ExAdEx Technology Contributes to the Development of VividEye™

ExAdEx-Innov Drives Innovation in Cosmetic Industry: Contributing to the Development of VividEye™ from Mibelle Biochemistry We are thrilled to announce ExAdEx-Innov’s contribution to the research and development of VividEye™, a new cosmetic product recently launched by Mibelle Biochemistry. This contribution showcases our commitment to driving innovation across industries and demonstrates the power of our ExAdEx […]

Poster session at IFSCC 2024 with Exsymol

Our Collaboration with Exsymol Monaco at the 34th Congress IFSCC Brazil 2024 We are excited to announce that our scientific research work performed in collaboration with our partner Exsymol Monaco, titled A Novel Micro-Physiological Model of Native Adipose Tissue for Assessing the Ability of a Silicium-Caffeine Complex to Prevent Fibro-Inflammation in Cellulite, will be presented during […]

ExAdEx NAM organoids to reduce animal experimentation

Organoid models developed by ExAdEx-Innov and collaborators presented at the 3R LÄND CONFERENCE 2024 in Tübingen (Germany) Latest work from ExAdEx-Innov team on clinically relevant non-animal method (NAM) for human adipose tissue research was selected for a poster presentation at the 3R LÄND Conference 2024 organized by the 3R-Center Tübingen for In vitro Models and […]

ExAdEx R&D platform on Skinobs Cosmetics Testing News

Our innovative R&D platform on human adipose tissue has been featured in Skinobs newsfeed and Skinobs preclinical database dedicated to cosmetics objectivation! ExAdEx ex vivo models represent an original approach for the evaluation and claim substantiation of cosmetic and nutraceutical ingredients for skin health, skin ageing and well-being, based on innovative and highly differentiating criteria. […]

Co-founder and KOL Christian Dani among World Top 2% Scientists

We are proud and happy for our collaborator and co-founder Dr Christian Dani from Institut de Biologie VaIrose and Université Côte d’Azur who was included in the latest World Ranking Top 2% Scientists list recently released by Stanford University. This ranking is considered the most prestigious worldwide, with 22 scientific fields and 176 subfields taken […]